Filling the need for trusted information on national health issues

New TB Medications, Shorter Regimens Could Transform Treatment For Drug-Resistant Strains

The Lancet: Changing the game for multidrug-resistant tuberculosis
“…New drugs and shorter regimens … could help improve the worrying, global situation for MDR-TB. The current treatment regimen is long and hard on patients, and there is already extensive resistance to existing second-line drugs…” (Ghanashyam, 3/19).